Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The study details page now displays a 403 Forbidden error instead of the original content. This blocks users from viewing the trial's details and related information.
    Difference
    0.5%
    Check dated 2026-09-26T16:07:46.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, showing the site branding and a minimal navigation. This indicates restricted access rather than an update to study data or page functionality.
    Difference
    20%
    Check dated 2026-09-19T18:55:54.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now includes a note about NIH grant/contract funding and the footer revision has been updated to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:05:24.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.4 to v3.6.5, indicating a small update to the study record page.
    Difference
    0.1%
    Check dated 2026-08-08T09:31:27.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-07-25T06:30:01.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The study record updated the status to Completed with no longer recruiting and posted results; enrollment is 33 with a completion date of 2026-03-12, and results were first posted on 2026-06-03, accompanied by expanded safety and response-criteria descriptions.
    Difference
    4%
    Check dated 2026-07-03T22:43:25.000Z thumbnail image

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.